Top

BMC Nephrology

Published in:

Open Access 01-12-2023 | Research

Effect of intradialytic oral nutritional supplementation on nutritional markers in malnourished chronic hemodialysis patients: prospective randomized trial

Authors: Mohamed Sary Gharib, Mariem Shaker Nazeih, Tamer Wahid El Said

Published in: BMC Nephrology | Issue 1/2023

Abstract

Background and objectives

Malnutrition is prevalent in chronic hemodialysis (HD) patients. It increases mortality and negatively affects quality of life. This study aimed to assess the effect of intradialytic oral nutritional supplement (ONS) on nutritional markers in chronic HD patients with protein energy wasting (PEW).

Methods

This 3-month prospective, open-label, randomized controlled trial included 60 chronic HD patients with PEW. The intervention group (30 patients) received intradialytic ONS and dietary counseling, whereas the control group (30 patients) received only dietary counseling. Nutritional markers were measured at the beginning and end of the study.

Results

The mean age of the patients was 54 ± 12.7 years, and that of the HD vintage was 64 ± 49.3 months. Compared to the control group, the intervention group showed a significant increase in serum albumin (p < 0.001), prealbumin (p < 0.001), cholesterol (p = 0.016), body mass index (BMI) (p = 0.019), serum creatinine/body surface area (BSA) (p = 0.016), and composite French PEW score (p = 0.002), as well as a significant decrease in high-sensitivity C-reactive protein (hs-CRP) (p = 0.001). The total iron binding capacity, normalized protein nitrogen appearance, and hemoglobin levels increased significantly in both groups.

Conclusion

Intradialytic ONS and dietary counseling for three months were more effective than dietary counseling alone in terms of improving nutritional status and inflammation in chronic HD patients, as evidenced by increases in serum albumin, prealbumin, BMI, serum creatinine/BSA, composite French PEW score, and a decrease in hs-CRP.

Carrero JJ, Thomas F, Nagy K, Arogundade F, Avesani CM, Chan M, Chmielewski M, Cordeiro AC, Espinosa-Cuevas A, Fiaccadori E, Guebre-Egziabher F, Hand RK, Hung AM, Ikizler TA, Johansson LR, Kalantar-Zadeh K, Karupaiah T, Lindholm B, Marckmann P, Mafra D, Parekh RS, Park J, Russo S, Saxena A, Sezer S, Teta D, Ter Wee PM, Verseput C, Wang AYM, Xu H, Lu Y, Molnar MZ, Kovesdy CP. Global prevalence of protein-energy wasting in kidney disease: a Meta-analysis of contemporary observational studies from the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018 Nov;28(6):380–92. https://doi.org/10.1053/j.jrn.2018.08.006.

Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Wanner C. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008 Feb;73(4):391–8. doi: https://doi.org/10.1038/sj.ki.5002585.

Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, Mitch WE, Price SR, Wanner C, Wang AY, ter Wee P, Franch HA. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013 Mar;23(2):77–90. https://doi.org/10.1053/j.jrn.2013.01.001.

Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, Kuhlmann MK, Stenvinkel P, TerWee P, Teta D, Wang AY, Wanner C. International Society of Renal Nutrition and Metabolism. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013 Dec;84(6):1096–107. https://doi.org/10.1038/ki.2013.147.

Moreau-Gaudry X, Jean G, Genet L, Lataillade D, Legrand E, Kuentz F, Fouque D. A simple protein-energy wasting score predicts survival in maintenance hemodialysis patients. J Ren Nutr. 2014 Nov;24(6):395–400. https://doi.org/10.1053/j.jrn.2014.06.008.

Chan W. Chronic kidney Disease and Nutrition Support. Nutr Clin Pract. 2021 Apr;36(2):312–30. https://doi.org/10.1002/ncp.10658.

Leon JB, Majerle AD, Soinski JA, Kushner I, Ohri-Vachaspati P, Sehgal AR. Can a nutrition intervention improve albumin levels among hemodialysis patients? A pilot study. J Ren Nutr. 2001 Jan;11(1):9–15. https://doi.org/10.1016/s1051-2276(01)79890-1.

Wilson B, Fernandez-Madrid A, Hayes A, Hermann K, Smith J, Wassell A. Comparison of the effects of two early intervention strategies on the health outcomes of malnourished hemodialysis patients. J Ren Nutr. 2001 Jul;11(3):166–71. https://doi.org/10.1053/jren.2001.24364.

Sezer S, Bal Z, Tutal E, Uyar ME, Acar NO. Long-term oral nutrition supplementation improves outcomes in malnourished patients with chronic kidney disease on hemodialysis. JPEN J Parenter Enteral Nutr. 2014 Nov;38(8):960–5. https://doi.org/10.1177/0148607113517266.

10.

Hiroshige K, Sonta T, Suda T, Kanegae K, Ohtani A. Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis. Nephrol Dial Transplant. 2001 Sep;16(9):1856–62. https://doi.org/10.1093/ndt/16.9.1856.

11.

Fouque D, McKenzie J, de Mutsert R, Azar R, Teta D, Plauth M, Cano N, Renilon Multicentre Trial Study Group. Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life. Nephrol Dial Transplant. 2008 Sep;23(9):2902–10. https://doi.org/10.1093/ndt/gfn131.

12.

Calegari A, Barros EG, Veronese FV, Thomé FS. Malnourished patients on hemodialysis improve after receiving a nutritional intervention. J Bras Nefrol 2011 Dec;33(4):394–401. PMID: 22189801.

13.

Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 2008 Dec;88(6):1511–8. doi: https://doi.org/10.3945/ajcn.2008.26665.

14.

Cupisti A, Kalantar-Zadeh K. Management of natural and added dietary phosphorus burden in kidney disease. Semin Nephrol. 2013 Mar;33(2):180–90. https://doi.org/10.1016/j.semnephrol.2012.12.018.

15.

Ikizler TA, Burrowes JD, Byham-Gray LD, KDOQI Nutrition in CKD Guideline Work Group, et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 update. Am J kidney diseases: official J Natl Kidney Foundation. 2020;76(3):1–S107.CrossRef

16.

Cano NJ, Fouque D, Roth H, Aparicio M, Azar R, Canaud B, Chauveau P, Combe C, Laville M, Leverve XM, French Study Group for Nutrition in Dialysis. Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol. 2007 Sep;18(9):2583–91. https://doi.org/10.1681/ASN.2007020184.

17.

Bolasco P, Caria S, Cupisti A, Secci R, Saverio Dioguardi F. A novel amino acids oral supplementation in hemodialysis patients: a pilot study. Ren Fail. 2011;33(1):1–5. https://doi.org/10.3109/0886022X.2010.536289.CrossRefPubMed

18.

Tomayko EJ, Kistler BM, Fitschen PJ, Wilund KR. Intradialytic protein supplementation reduces inflammation and improves physical function in maintenance hemodialysis patients. J Ren Nutr. 2015 May;25(3):276–83. https://doi.org/10.1053/j.jrn.2014.10.005.

19.

Moretti HD, Johnson AM, Keeling-Hathaway TJ. Effects of protein supplementation in chronic hemodialysis and peritoneal dialysis patients. J Ren Nutr. 2009 Jul;19(4):298–303. https://doi.org/10.1053/j.jrn.2009.01.029.

20.

Cheu C, Pearson J, Dahlerus C, Lantz B, Chowdhury T, Sauer PF, Farrell RE, Port FK, Ramirez SP. Association between oral nutritional supplementation and clinical outcomes among patients with ESRD. Clin J Am Soc Nephrol. 2013 Jan;8(1):100–7. https://doi.org/10.2215/CJN.13091211.

21.

Pupim LB, Majchrzak KM, Flakoll PJ, Ikizler TA. Intradialytic oral nutrition improves protein homeostasis in chronic hemodialysis patients with deranged nutritional status. J Am Soc Nephrol. 2006 Nov;17(11):3149–57. https://doi.org/10.1681/ASN.2006040413.

22.

Scott MK, Shah NA, Vilay AM, Thomas J 3rd, Kraus MA, Mueller BA. Effects of peridialytic oral supplements on nutritional status and quality of life in chronic hemodialysis patients. J Ren Nutr 2009 Mar;19(2):145–52. doi: https://doi.org/10.1053/j.jrn.2008.08.004.

23.

Lacson E Jr, Wang W, Zebrowski B, Wingard R, Hakim RM. Outcomes associated with intradialytic oral nutritional supplements in patients undergoing maintenance hemodialysis: a quality improvement report. Am J kidney diseases: official J Natl Kidney Foundation. 2012;60(4):591–600.CrossRef

24.

Chen JB, Cheng BC, Yang CH, Hua MS. An association between time-varying serum albumin level and the mortality rate in maintenance haemodialysis patients: a five-year clinical cohort study. BMC Nephrol 2016 Aug 20;17(1):117. doi: https://doi.org/10.1186/s12882-016-0332-5.

25.

Lukowsky LR, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K. Nutritional predictors of early mortality in incident hemodialysis patients. Int Urol Nephrol. 2014 Jan;46(1):129–40. https://doi.org/10.1007/s11255-013-0459-2.

26.

Kittiskulnam P, Banjongjit A, Metta K, Tiranathanagul K, Avihingsanon Y, Praditpornsilpa K, Tungsanga K, Eiam-Ong S. The beneficial effects of intradialytic parenteral nutrition in hemodialysis patients with protein energy wasting: a prospective randomized controlled trial. Sci Rep 2022 Mar 16;12(1):4529. doi: https://doi.org/10.1038/s41598-022-08726-8.

27.

Rambod M, Kovesdy CP, Bross R, Kopple JD, Kalantar-Zadeh K. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr 2008 Dec;88(6):1485–94. doi: https://doi.org/10.3945/ajcn.2008.25906.

28.

Boyd E. The growth of the surface area of the human body. J Am Stat Assoc. 1936;31:765–6.CrossRef

29.

Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993 Nov;4(5):1205–13. https://doi.org/10.1681/ASN.V451205.

30.

Depner TA, Daugirdas JT. Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol. 1996 May;7(5):780–5. https://doi.org/10.1681/ASN.V75780.

31.

Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001 Dec;38(6):1251–63. https://doi.org/10.1053/ajkd.2001.29222.

32.

Kopple JD. Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis. 1994 Dec;24(6):1002–9. https://doi.org/10.1016/s0272-6386(12)81075-4.

33.

Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier J, Avram MM. Predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 1993 Mar;3(9):1613–22. https://doi.org/10.1681/ASN.V391613.

34.

Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant. 2005 Sep;20(9):1880–8. https://doi.org/10.1093/ndt/gfh941.

35.

Evans DC, Corkins MR, Malone A, Miller S, Mogensen KM, Guenter P, Jensen GL, ASPEN Malnutrition Committee. The Use of visceral proteins as Nutrition markers: an ASPEN position paper. Nutr Clin Pract. 2021 Feb;36(1):22–8. https://doi.org/10.1002/ncp.10588.

36.

Caglar K, Fedje L, Dimmitt R, Hakim RM, Shyr Y, Ikizler TA. Therapeutic effects of oral nutritional supplementation during hemodialysis. Kidney Int. 2002 Sep;62(3):1054–9. https://doi.org/10.1046/j.1523-1755.2002.00530.x.

37.

Caetano C, Valente A, Silva FJ, Antunes J, Garagarza C. Effect of an intradialytic protein-rich meal intake in nutritional and body composition parameters on hemodialysis patients. Clin Nutr ESPEN. 2017 Aug;20:29–33. https://doi.org/10.1016/j.clnesp.2017.04.003.

38.

Kalantar-Zadeh K, Kleiner M, Dunne E, Ahern K, Nelson M, Koslowe R, Luft FC. Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis. 1998 Feb;31(2):263–72. https://doi.org/10.1053/ajkd.1998.v31.pm9469497.

Title: Effect of intradialytic oral nutritional supplementation on nutritional markers in malnourished chronic hemodialysis patients: prospective randomized trial
Authors: Mohamed Sary Gharib
Mariem Shaker Nazeih
Tamer Wahid El Said
Publication date: 01-12-2023
Publisher: BioMed Central
Published in: BMC Nephrology / Issue 1/2023
Electronic ISSN: 1471-2369
DOI: https://doi.org/10.1186/s12882-023-03181-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background and objectives

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

Continuous venovenous hemodiafiltration versus standard medical therapy for the prevention of rhabdomyolysis-induced acute kidney injury: a retrospective cohort study

Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study

Receiving hemodialysis in Hispanic ethnic dense communities is associated with better adherence and outcomes among young patients: a retrospective analysis of the Dialysis Outcomes and Practice Patterns Study

Risk factors of hemodialysis catheter dysfunction in patients undergoing continuous renal replacement therapy: a retrospective study

Effects of serum sodium and chloride levels in the outcome of critically ill pediatric patients in the post-operative period of liver transplantation

Relationship between arterial stiffness, left ventricular diastolic function, and renal function in chronic kidney disease

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials